Eurazeo Capital Acquires D.O.R.C. from Montagu

Eurazeo Acquires Majority Stake in Cranial Technologies

March 8, 2022

Healthcare Services

Eurazeo has acquired a majority stake in Cranial Technologies from BPOC, investing over $200 million alongside an equity rollover from management. Cranial Technologies is the market leader in custom cranial orthotics (the DOC Band) and operates approximately 80 U.S. clinics plus licensed international locations; the investment will support U.S. and international expansion and product-line extension.

WorldCare Clinical Acquires Digital Angiography Reading Center (DARC)

September 3, 2021

Healthcare Services

WorldCare Clinical, a portfolio company of DFW Capital Partners, has acquired New York-based Digital Angiography Reading Center (DARC), a leading ophthalmology imaging core lab. The add-on expands WorldCare Clinical's retinal and ophthalmic imaging capabilities and leverages WCC's global imaging CRO platform to support sponsors in clinical trials worldwide.

EssilorLuxottica Acquires Optegra from MidEuropa

May 30, 2025

Healthcare Services

EssilorLuxottica has agreed to acquire Optegra, a leading European ophthalmology platform, from private equity firm MidEuropa. The transaction — subject to customary antitrust clearance and expected to close later this year — gives EssilorLuxottica a network of 70+ eye hospitals and diagnostic facilities across Europe and expands its clinical ophthalmology capabilities and European footprint.

MidEuropa Acquires Majority Stake in Optegra Eye Health Care

February 22, 2023

Healthcare Services

MidEuropa has completed the acquisition of a majority stake in Optegra Eye Health Care from H2 Equity Partners, with H2 and Optegra management reinvesting alongside MidEuropa. Optegra is a multi‑national ophthalmology platform operating 29 specialist facilities across the UK, Poland, Czech Republic and Slovakia and performs over 100,000 surgical procedures per year; MidEuropa intends to accelerate the company’s geographic expansion and growth across Europe.

Rho Acquires Dokumeds

December 8, 2021

Healthcare Services

Rho, a privately held full-service contract research organization (CRO) based in Research Triangle Park/Durham, North Carolina, has acquired Dokumeds, a privately held European CRO headquartered in Riga, Latvia. The acquisition expands Rho's global footprint and clinical development capabilities, providing clients broader access to patients and multinational trial support; terms were not disclosed.

Alcon Acquires Aerie Pharmaceuticals

August 22, 2022

Pharmaceuticals

Swiss eye-care leader Alcon has acquired Aerie Pharmaceuticals, a Durham, North Carolina-based ophthalmic pharmaceutical company, adding commercial products Rocklatan and Rhopressa as well as a clinical-stage pipeline including AR-15512. The acquisition strengthens Alcon's ophthalmic pharmaceutical capabilities and R&D expertise and is intended to expand distribution and accelerate development of Aerie's portfolio.